Publication: Salbutamol in acute organophosphorus insecticide poisoning–a pilotdose-response phase II study
Issued Date
2018-09-02
Resource Type
ISSN
15569519
15563650
15563650
Other identifier(s)
2-s2.0-85042217956
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Toxicology. Vol.56, No.9 (2018), 820-827
Suggested Citation
Fazle Rabbi Chowdhury, Md Mustafezur Rahman, Parash Ullah, Abdul Mumith Ruhan, Md Shafiqul Bari, M. M.Jahangir Alam, Md Moyeen Uddin, Shomik Maruf, Md Ismail Patwary, Michael Eddleston Salbutamol in acute organophosphorus insecticide poisoning–a pilotdose-response phase II study. Clinical Toxicology. Vol.56, No.9 (2018), 820-827. doi:10.1080/15563650.2018.1440587 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/47299
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Salbutamol in acute organophosphorus insecticide poisoning–a pilotdose-response phase II study
Other Contributor(s)
Abstract
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Background: Treatment of acute organophosphorus (OP) insecticide poisoning is difficult, with many patients dying despite best care. Pre-clinical studies have shown benefit from salbutamol, possibly due speeding alveolar fluid clearance or reducing bronchoconstriction. In this small pilot dose-response study, we aimed to explore whether addition of nebulized salbutamol to standard care might improve resuscitation. Methods: We performed a single-blind phase II study comparing the effect of two different doses of nebulized salbutamol versus saline placebo, in addition to standard treatment. Primary outcome was oxygen saturations over the first 60 min of resuscitation; secondary outcomes included heart rate, incidence of dysrhythmias, time to ‘atropinization’, atropine dose required, and mortality. Result: Seventy-five patients were randomized to receive 5 mg (Salb5, n = 25) or 2.5mg (Salb2.5, n = 25) of salbutamol, or saline placebo (NoSalb, n = 25), by nebulizer. Oxygen saturations did not differ between groups over the first 60 min of resuscitation (median AUC NoSalb: 1376 [95% CI 1282 to 1470], Salb2.5: 1395 [1305 to 1486], Salb5: 1233 [1100 to 1367]; p =.9898). Heart rate was also similar across the three arms. Median time to full atropinization, and atropine dose required, were the same for all three arms (NoSalb 15.0 [10–16] min and 12.6 [8.0–13.4] mg, Salb2.5 15.0 [10–16] min and 12.6 [9.3–16.8] mg, and Salb5 15.0 [10–20] min and 12.6 [10.7–20.6] mg; p =.4805 and p =.1871, respectively). Three (12%) patients died in the Salb2.5 and Salb5 groups and two (8%) in the NoSalb group. Conclusion: This pilot study, within the limitations of its small size and variation between patients, found no apparent evidence that administration of nebulized salbutamol improved resuscitation of patients with acute OP insecticide self-poisoning. The data obtained provides a basis to design further studies to ultimately test the role of salbutamol in OP insecticide poisoning.